Page 87 - The Vasculitides, Volume 1: General Considerations and Systemic Vasculitis

Overview of Primary and Secondary Vasculitides 63

[247] Boonyapisit, K., Katirji, B. Severe exacerbation of hepatitis C-associated vasculitic
neuropathy following treatment with interferon alpha: a case report and literature
review. Muscle Nerve 2002; 25:909-913.

[248] Saadoun, D., Pol, S., Ziza, J. M., et al. Ribavirin/protease inhibitor combination in
hepatitis C virus associated mixed cryoglobulinemia vasculitis/Peg-INFa [Abstract].
Presse Med. 2013; 42:694-695.

[249] Weiss, P. F., Feinstein, J. A., Luan, X., et al. Effects of corticosteroid on Henoch-
Schonlein purpura: a systematic review. Pediatrics 2007; 120:1079-1087.

[250] Ren, P., Han, F., Chen, L., et al. The combination of mycophenolate mofetil with
corticosteroids induces remission of Henoch-Schonlein purpura nephritis. Am. J.
Nephrol. 2012; 36:271-277.

[251] Nikibakhhsh, A. A., Mahmoodzahel, H., Karamyyar, M., et al. Treatment of severe
Henoch-Schonlein purpura nephritis with mycophenolate mofetil. Saudi J. Kidney Dis.
Transpl. 2014; 25:858-863.

[252] Gluth, M. B., Baratz, K. H., Matteson, E. L., et al. Cogan syndrome: A retrospective
review of 60 patients throughout a half century. Mayo Clin. Proc. 2006; 81:483-488.

[253] Noel, N., Wechsler, B., Le Thi, Huong Boutin, D., et al. Outcome of neuro-Behçet:
analysis of a large cohort [Abstract]. Presse Med. 2013; 42:692.

[254] Shugaiv, E., Tüzün, E., Mutlu, M., et al. Mycophenolate mofetil as a novel
immunosuppressant in the treatment of neuro-Behçet?s disease with parenchymal
involvement: presentation of four cases. Clin. Exp. Rheumatol. 2011; 29(4 Suppl. 67):
S64-S67.

[255] Nanthapisal, S., Eleftheriou, D., Hong, Y., et al. Behçet disease in children: the Great
Ormond Street Hospital experience [Abstract]. Presse Med. 2013; 42:651.

[256] Hajj-Ali, R. A., Calabrese, L. H. Central nervous system vasculitis. Curr. Opin.
Rheumatol. 2009; 21:10-18.

[257] Benseler, S. M., Silverman, E., Aviv, R. I., et al. Primary central nervous system
vasculitis in children. Arthritis Rheum. 2006; 54:1291-1297.

[258] Pagnoux, C., de Boyson, H. How to treat primary vasculitis of the central nervous
system [Abstract]. Presse Med. 2013; 42:605-607.

[259] Lourdudoss, C., Vollenhoven, R. V. Mycophenolate mofetil in the treatment of SLE
and systemic vasculitis: experience at a single university center. Lupus 2014; 23:299-
304.

[260] Buch, M. H., Smolen, J. S., Betteridge, N., et al. Updated consensus statement on the
use of rituximab in patients with rheumatoid arthritis. Ann. Rheum. Dis. 2011; 70:909-
920.

[261] Puéchal, X. Rheumatoid arthritis vasculitis [Abstract]. Presse Med. 2013; 42:527-530.

Complimentary Contributor Copy